[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:picalm-mllt10":3},{"name":4,"total":5,"recruiting":5,"trials":6},"PICALM::MLLT10",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06177067","Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia",[11],"Phase 1","RECRUITING","2026-08-26T02:19:29.119921Z","2026-05-05T02:43:27.978998Z"]